CAI · Caris Life Sciences, Inc.
$21.80
-0.38 (-1.71%)
At close · Aug 14
Market Cap
$6.16B
Shares
282.60M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-08-07 | GEORGE H POSTE | Director | 30,000 | 2026-08-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-03 | GEORGE H POSTE | Director | 20,000 | 2026-08-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-11 | LUKE POWER | Officer | 62,250 | 2025-12-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–3 of 3 filings
Key facts
CIK
2019410
CUSIP
142152107
13F (30d)
232 filings
231 filers
Visit website
Investor relations